Lonza | LONN - Current Assets

Stock Price
479.80
Daily Change
-19.30 -3.87%
Monthly
-1.19%
Yearly
-16.38%
Q2 Forecast
470.40

Lonza reported CHF8B in Current Assets for its fiscal semester ending in December of 2025.





Current Assets Change Date
Akzo Nobel EUR 7.53B 1.47B Mar/2026
Alcon AG USD 6.45B 116M Dec/2025
Almirall EUR 713.98M 69K Dec/2025
AstraZeneca USD 28.72B 1.22B Dec/2025
BASF EUR 31.68B 1.4B Dec/2025
Bayer EUR 32.91B 30M Dec/2025
Beiersdorf EUR 6.66B 8M Dec/2025
Covestro EUR 5.91B 259M Dec/2025
Demant DKK 10.08B 128M Dec/2025
Fresenius EUR 12.06B 1.18B Sep/2025
Fresenius Medical Care EUR 7.9B 74M Dec/2025
Geberit CHF 1.13B 151.3M Dec/2024
Genmab DKK 2.88B 1.59B Dec/2025
Givaudan CHF 4.07B 258M Dec/2025
GlaxoSmithKline GBP 17.51B 332M Dec/2025
GN Store Nord DKK 8.64B 105M Dec/2025
Hikma Pharmaceutical USD 2.64B 86M Dec/2025
Johnson Matthey GBP 3.83B 320M Dec/2025
Merck EUR 13.23B 354M Dec/2025
Novartis USD 30.46B 2.26B Dec/2025
Philips EUR 9.93B 654M Dec/2025
Roche Holding CHF 38.73B 3.03B Dec/2025
Sanofi EUR 30.16B 789M Mar/2026
Sika AG CHF 4.41B 242.1M Dec/2025
Smith & Nephew USD 4.63B 169M Dec/2025
Solvay EUR 2.16B 45M Dec/2025
UCB EUR 6.05B 733M Dec/2025